Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 2
1992 2
1993 2
1994 5
1995 2
1996 4
1997 2
1998 4
1999 3
2000 2
2001 2
2002 3
2003 1
2004 6
2005 7
2006 7
2007 6
2008 7
2009 10
2010 10
2011 13
2012 11
2013 15
2014 4
2015 6
2016 4
2017 7
2018 8
2019 5
2020 7
2021 5
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.
Response.
Xu Y, Zheng M, Khuong A, Merritt RE, Shrager JB, Wakelee HA, Kratzke RA, Hoang CD. Xu Y, et al. Among authors: kratzke ra. Chest. 2013 Dec;144(6):1971-1972. doi: 10.1378/chest.13-1931. Chest. 2013. PMID: 24297135 No abstract available.
A tri-specific killer engager against mesothelin targets NK cells towards lung cancer.
Kennedy PR, Vallera DA, Ettestad B, Hallstrom C, Kodal B, Todhunter DA, Bendzick L, Hinderlie P, Walker JT, Pulkrabek B, Pastan I, Kratzke RA, Fujioka N, Miller JS, Felices M. Kennedy PR, et al. Among authors: kratzke ra. Front Immunol. 2023 Feb 22;14:1060905. doi: 10.3389/fimmu.2023.1060905. eCollection 2023. Front Immunol. 2023. PMID: 36911670 Free PMC article.
Oncolytic Viral Therapy for Mesothelioma.
Pease DF, Kratzke RA. Pease DF, et al. Among authors: kratzke ra. Front Oncol. 2017 Aug 24;7:179. doi: 10.3389/fonc.2017.00179. eCollection 2017. Front Oncol. 2017. PMID: 28884088 Free PMC article. Review.
Epigenetics of lung cancer.
Langevin SM, Kratzke RA, Kelsey KT. Langevin SM, et al. Among authors: kratzke ra. Transl Res. 2015 Jan;165(1):74-90. doi: 10.1016/j.trsl.2014.03.001. Epub 2014 Mar 12. Transl Res. 2015. PMID: 24686037 Free PMC article. Review.
Meet the new boss: lung cancer staging.
Begnaud A, Kratzke RA. Begnaud A, et al. Among authors: kratzke ra. J Thorac Dis. 2018 Mar;10(3):1329-1331. doi: 10.21037/jtd.2018.03.89. J Thorac Dis. 2018. PMID: 29708135 Free PMC article. No abstract available.
A Turning Point for Mesothelioma Therapy.
Kulkarni AA, Kratzke RA. Kulkarni AA, et al. Among authors: kratzke ra. JCO Oncol Pract. 2022 Feb;18(2):125-126. doi: 10.1200/OP.21.00608. Epub 2021 Oct 15. JCO Oncol Pract. 2022. PMID: 34652951 No abstract available.
The pathogenesis of mesothelioma.
Carbone M, Kratzke RA, Testa JR. Carbone M, et al. Among authors: kratzke ra. Semin Oncol. 2002 Feb;29(1):2-17. doi: 10.1053/sonc.2002.30227. Semin Oncol. 2002. PMID: 11836664 Review.
157 results